OncoSec Medical Inc (ONCSQ)

[chickpea598]

The International Bioelectrics Symposium on the 12th could give us an indication of where Oncosec is headed with the next generation electroporation device.

So far we have evidence from mouse models that they are able to optimize gene electrotransfer and that the new helical needle creates a 3-fold increase in surface area for DNA-tissue interaction. The device will allow the application of intratumoral IL-12 gene immunotherapy to a broad range of deep tissue cancers.

I think the announcement of a new gene candidate and initiation of a phase 1 trial will use this next generation EP device to test the "multi gene" delivery ability Punit spoke of.